Every Form 4 that ZOETIS INC. (ZTS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ZTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZTS filings page.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported equity compensation activity involving restricted stock units (RSUs) and common stock. On February 19, 2026, RSUs converted into 386 shares of Zoetis common stock, increasing his directly held common shares.
On the same date, 154 common shares were disposed of at $127.28 per share to satisfy tax withholding obligations, a non‑open‑market transaction. After these transactions, Sarbaugh directly owned 2,342 Zoetis common shares and held multiple RSU awards under the Zoetis Amended and Restated 2013 Equity and Incentive Plan, which generally vest in three equal installments on the first, second, and third anniversaries of their grant dates.
Zoetis Inc. Executive Vice President Rimma Driscoll reported equity transactions involving restricted stock units and common shares. On February 19, 2026, she acquired 454.6338 restricted stock units through an exercise or conversion of derivative securities and received 454 shares of Zoetis common stock at a price of $0.00 per share upon RSU vesting and settlement.
On the same date, 179 shares of common stock were disposed of at $127.28 per share to satisfy tax withholding obligations related to these awards. After these transactions, she held 5,715 shares of common stock directly. Footnotes state that each RSU represents a right to receive one share of Zoetis common stock, generally vesting in one-third increments on the first, second, and third anniversaries of the respective grant dates, subject to continued service and certain earlier vesting events.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette reported equity award activity involving restricted stock units (RSUs) and common shares. On February 19, 2026, RSUs covering 431.6543 units were exercised or converted, resulting in the acquisition of 431 shares of Zoetis common stock.
On the same date, 190 common shares were disposed of at $127.28 per share in a tax-withholding transaction to satisfy tax obligations associated with the equity award, rather than an open-market sale. After these transactions, the reporting person directly held 1,684 common shares and RSU holdings of 2,197 and 207 units in separate grants, each RSU representing a contingent right to receive one share of common stock subject to multi-year vesting schedules and continued service conditions.
Zoetis Inc. director Sanjay Khosla reported equity award activity involving restricted and deferred stock units. On February 19, 2026, 1,619.3325 restricted stock units were exercised and converted into an equal number of deferred stock units at no cash cost.
These deferred stock units are fully vested, accrue dividend equivalents, and each unit corresponds to one share of Zoetis common stock. Following the grant, Khosla directly held 11,620.8453 deferred stock units and 1,936 restricted stock units. Deferred units will be paid in Zoetis shares after his board service ends or upon specified change-in-control or termination events.
Zoetis Inc. director Antoinette Renee Leatherberry reported equity award activity involving restricted stock units (RSUs) and common stock. On February 19, 2026, she exercised or converted RSUs into 1,619 shares of Zoetis common stock, with each RSU delivering one share upon vesting.
The filing shows 406 shares of common stock were disposed of to Zoetis Inc. in exchange for cash based on the closing share price of $127.28 as of the vesting date. After these transactions, she directly owned 5,280 shares of Zoetis common stock and held 1,936 RSUs that represent contingent rights to receive additional shares, subject to vesting conditions.
Zoetis Inc. director Paul Bisaro acquired common stock through the vesting and settlement of restricted stock units. On February 19, 2026, 1,619.3325 RSUs were exercised or converted, resulting in the acquisition of 1,619 shares of Zoetis common stock at a stated price of $0.00 per share.
After these transactions, he directly owned 25,862 shares of Zoetis common stock. He also held 1,936 restricted stock units, each representing a contingent right to receive one share of Zoetis common stock, which are scheduled to vest and settle on the first anniversary of their grant date, February 18, 2026, subject to continued service and certain earlier vesting events.
Zoetis Inc. director Frank A. D'Amelio reported equity award and deferral activity involving company stock units. On February 19, 2026, previously granted restricted stock units were converted into 1,619.3325 deferred stock units (DSUs) under a voluntary deferral. After this grant and related accruals, he directly holds 11,620.8453 DSUs, each representing one share of Zoetis common stock to be settled after his board service ends. He also directly holds 1,936 restricted stock units (RSUs), which are scheduled to vest and be settled in shares on the first anniversary of their grant, February 18, 2026, subject to continued service and certain earlier-vesting events.
Zoetis Inc. director Louise M. Parent reported equity award activity involving restricted stock units (RSUs). On February 19, 2026, RSUs were exercised into 1,619 shares of common stock, increasing her direct common stock holdings to 16,879 shares. The filing also records a disposition of 615 shares back to Zoetis Inc. for cash based on the closing share price of $127.28, leaving 16,264 common shares directly held. Following these transactions, she also directly holds 1,936 RSUs, each representing a contingent right to receive one Zoetis common share, with future RSUs scheduled to vest and settle in shares on the first anniversary of their grant dates.
Zoetis Inc. director Willie M. Reed acquired company stock through restricted stock unit (RSU) vesting. On February 19, 2026, 1,619.3325 RSUs were exercised at $0.0000 per share, resulting in 1,619 shares of Zoetis common stock being issued.
Following the transaction, Reed directly owned 12,864 Zoetis common shares and held 1,936 RSUs, each representing a right to receive one share. The remaining RSUs are scheduled to vest and be settled in Zoetis common stock on February 18, 2026, subject to continued service and certain earlier-vesting events.
Zoetis Inc. director Sanjay Khosla reported an equity award in the form of restricted stock units. He acquired 1,936 RSUs on February 18, 2026 under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. Each RSU represents a contingent right to receive one share of Zoetis common stock.
The footnotes state these RSUs will vest and be settled in Zoetis common shares on the first anniversary of the grant date, February 18, 2026, subject to his continued service and certain earlier-vesting events. The filing also updates holdings from a prior RSU grant scheduled to vest on February 19, 2025.
Esch Kevin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Kevin Esch received new equity awards on February 18, 2026. He was granted 4,026 restricted stock units and 15,931 stock options at a price of $0 per unit or option. Each RSU represents a contingent right to one Zoetis common share.
One-third of each RSU and one-third of each option will vest on the first, second, and third anniversaries of the grant date, February 18, 2026, subject to his continued service and possible earlier vesting upon certain specified events. Each option expires on the tenth anniversary of the grant date.
Bisaro Paul reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Paul Bisaro reported an equity compensation award in the form of 1,936 restricted stock units on February 18, 2026. These RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan and represent a contingent right to receive an equal number of Zoetis common shares.
Each RSU will vest and be settled in Zoetis common stock on the first anniversary of the grant date, February 18, 2026, subject to his continued service and certain earlier‑vesting events. A separate line reflects his existing RSU holdings, which totaled 1,619.3325 units after earlier grants and related dividend equivalents.
Zoetis Inc. reported that Executive Vice President Ferran Astorga Jeannette received new equity awards. On February 18, 2026, the executive was granted 2,197 restricted stock units and 8,693 stock options at an exercise price of $0.00 per option.
Each restricted stock unit represents a contingent right to receive one share of Zoetis common stock. One-third of both the RSUs and stock options will vest on the first, second, and third anniversaries of the February 18, 2026 grant date, subject to continued service and earlier vesting upon certain specific events.
Tilenius Stephanie reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Stephanie Tilenius reported an equity award of 1,936 restricted stock units (RSUs). The RSUs were granted at no cash cost under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
Each RSU represents a contingent right to receive one share of Zoetis common stock. These RSUs are scheduled to vest and settle in shares on the first anniversary of the grant date, February 18, 2026, assuming continued service and subject to earlier vesting upon certain specified events. Following the reported transactions, Tilenius directly holds 1,972.4463 RSUs, including units from a prior grant dated December 1, 2025 that vest on its first anniversary.
Sarbaugh Keith reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported new equity awards. On February 18, 2026, he received 2,674 restricted stock units and 10,581 stock options under the Zoetis Amended and Restated 2013 Equity and Incentive Plan.
The RSUs each represent one share of common stock and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. The stock options also vest one‑third per year over three years from the grant date and expire on the tenth anniversary.
DAMELIO FRANK A reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Frank A. D'Amelio reported an equity compensation award of 1,936 restricted stock units (RSUs) granted on February 18, 2026 under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. The award was recorded at a price of $0.00 per unit, reflecting that this is a grant, not a market purchase.
Each RSU represents a contingent right to receive one share of Zoetis common stock. According to the terms described, each RSU will vest and be settled in Zoetis common shares on the first anniversary of the date of grant, February 18, 2026, subject to D'Amelio's continued service and certain earlier-vesting events.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Julie Fuller reported new equity awards in the latest Form 4. On February 18, 2026, she was granted 3,626 restricted stock units and 14,345 stock options under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
Each RSU represents a right to receive one share of Zoetis common stock, with one-third of the RSUs scheduled to vest on each of the first, second and third anniversaries of the February 18, 2026 grant date, subject to continued service and certain earlier-vesting events. The stock options vest on the same one-third annual schedule and each option expires on the tenth anniversary of the grant date.
Norden Gregory reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Gregory Norden reported an equity award of 1,936 restricted stock units (RSUs) on February 18, 2026, granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan. Each RSU represents a contingent right to receive one share of Zoetis common stock and will vest on the first anniversary of the grant date, subject to his continued service and certain earlier-vesting events.
MCCALLISTER MICHAEL B reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Michael B. McCallister received an equity award of 1,936 restricted stock units on February 18, 2026. The award was granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan and includes related dividend equivalent units. Each unit represents a right to receive one share of Zoetis common stock. These RSUs vest and settle in shares on the first anniversary of the grant date, February 18, 2026, if he continues in service, with provisions for earlier vesting upon certain specified events. McCallister also reports 1,619.3325 previously granted RSUs that are scheduled to vest and settle on February 19, 2025, subject to similar service and early-vesting conditions.
PARENT LOUISE M reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Louise M. Parent reported an equity award of 1,936 restricted stock units (RSUs). The RSUs were granted at a price of $0.00 per unit and increase her directly held RSU balance to 1,936 units from this grant.
Each RSU represents a contingent right to receive one share of Zoetis common stock. According to the terms, these RSUs are scheduled to vest and be settled in shares on the first anniversary of the grant date, February 18, 2026, subject to her continued service and certain earlier-vesting events.
The filing also shows a separate RSU holding line with 1,619.3325 RSUs, which relates to a prior grant scheduled to vest on February 19, 2025 under similar continued-service conditions.
Stetter Mark reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Mark Stetter received a grant of 1,936 restricted stock units (RSUs) of Zoetis common stock. Each RSU represents the right to receive one Zoetis share and is issued at no cash cost, vesting after one year of continued service, subject to certain early-vesting events.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano reported equity awards on February 18, 2026. She received 3,664 restricted stock units and 14,499 stock options for Zoetis common stock, granted under the company’s equity and incentive plan.
Each RSU represents a right to one Zoetis share and is scheduled to vest in three equal installments on the first, second, and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. The stock options also vest in three equal annual installments and expire on the tenth anniversary of the grant date.
Zoetis Inc. director Antoinette Renee Leatherberry reported an equity award in the form of restricted stock units (RSUs). She acquired 1,936 RSUs at a stated price of $0.00 per unit, bringing this award to 1,936 RSUs. Each RSU represents a contingent right to receive one share of Zoetis common stock. According to the footnotes, these RSUs will vest and be settled in shares on the first anniversary of the grant date, February 18, 2026, subject to her continued service and certain earlier-vesting events. A separate line shows 1,619.3325 RSUs outstanding from a prior grant that is scheduled to vest and settle on February 19, 2025, under similar continued-service conditions.
Reed Willie M reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Willie M. Reed reported an equity award of 1,936 restricted stock units (RSUs) granted on February 18, 2026 at a price of $0.00 per unit. Each RSU represents a contingent right to receive one share of Zoetis common stock and was granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, including related dividend-equivalent units. According to the terms, these RSUs will vest and be settled in Zoetis common shares on the first anniversary of the grant date, February 18, 2026, subject to Reed’s continued service and certain earlier-vesting events.
Broadhurst Vanessa reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Vanessa Broadhurst received a grant of 1,936 restricted stock units (RSUs) on February 18, 2026 under the company’s equity and incentive plan. Each RSU represents a contingent right to one Zoetis common share and will vest on the first anniversary of the grant, subject to continued service and certain earlier-vesting events.
Hattersley Gavin reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. director Gavin Hattersley reported an equity award of 1,936 restricted stock units (RSUs) on February 18, 2026 at a stated price of $0.00 per unit, reflecting a grant under the company’s Amended and Restated 2013 Equity and Incentive Plan.
Each RSU represents a contingent right to receive one share of Zoetis common stock and will vest and be settled on the first anniversary of the grant date, February 18, 2026, subject to his continued service and certain earlier vesting conditions. Following these transactions, Hattersley directly holds RSUs including 1,619.3325 units from a prior grant scheduled to vest on February 19, 2025.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll reported equity awards under the company’s Amended and Restated 2013 Equity and Incentive Plan. On February 18, 2026, she received 2,323 restricted stock units (RSUs) and 9,191 stock options, each RSU representing one share of common stock.
One-third of the new RSUs and one-third of the options vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier‑vesting events. Each option allows her to buy Zoetis common stock and expires on the tenth anniversary of its grant.
PECK KRISTIN C reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. reported that Chief Executive Officer Kristin C. Peck received new equity awards. On February 18, 2026, she was granted 28,072 restricted stock units (RSUs) and 111,060 stock options at no cost, as compensation awards.
Each RSU represents a contingent right to one share of Zoetis common stock and, according to the plan terms, one-third of each RSU and one-third of each option will vest on the first, second, and third anniversaries of the February 18, 2026 grant date, subject to continued service and certain earlier vesting events. The options expire on the tenth anniversary of the grant date.
Ashton Nicholas reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Nicholas Ashton reported equity awards consisting of restricted stock units (RSUs) and stock options. On February 18, 2026, he received a grant of 4,148 RSUs and 16,413 stock options under the Zoetis Amended and Restated 2013 Equity and Incentive Plan.
Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of each RSU and one-third of each option vest on the first, second and third anniversaries of the grant date, subject to his continued service and certain earlier vesting events. Each option expires on the tenth anniversary of its grant date.
Zoetis Inc. Executive Vice President Jamie Brannan received new equity awards. On February 18, 2026, Brannan was granted 5,399 restricted stock units and 21,361 stock options, each at an exercise price of $0.00 per unit or option.
Each RSU represents a contingent right to receive one share of Zoetis common stock. One-third of the RSUs and one-third of the options will vest on each of the first, second and third anniversaries of the grant date, subject to continued service and certain earlier-vesting events. Following these grants, Brannan directly holds RSUs and multiple option positions reflecting prior annual awards under the company’s equity and incentive plans.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported new equity awards and updated holdings. On February 18, 2026 he received grants of 8,605 restricted stock units and 34,045 stock options at a price of $0.00 per share, vesting in three annual installments, alongside disclosures of existing option and RSU positions.
Zoetis Inc. Chief Executive Officer Kristin C. Peck reported exercising stock options for 20,000 shares of Zoetis common stock at an exercise price of $41.83 per share on February 17, 2026. On the same day, she completed preplanned open‑market sales totaling 20,000 shares under a Rule 10b5‑1 trading plan.
The sales were split into 9,200 shares at a weighted average price of $126.4601 (with individual trades ranging from $126.01 to $126.98) and 10,800 shares at a weighted average price of $127.5492 (with trades from $127.01 to $127.56). Following these transactions, she directly held 101,337 shares of common stock and indirectly held 833.6435 common stock equivalents through the Zoetis 401(k) savings plan as of December 31, 2025, along with substantial remaining stock options.
Zoetis Inc. executive Kevin Esch reported routine equity compensation activity. On February 6 and 8, 2026, he acquired 43 and 50 shares of Zoetis common stock, respectively, through the vesting and settlement of restricted stock units.
On those same dates, he disposed of 15 and 18 shares of common stock at $127.42 per share. Following these transactions, he directly held 327 shares of Zoetis common stock and indirectly held 122.9323 common stock equivalents in the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025. He also reported outstanding restricted stock units covering 44, 307.4298 and 775.5724 shares of common stock, subject to multi‑year vesting schedules tied to continued service.
Zoetis Inc. executive Ashton Nicholas reported routine equity activity tied to restricted stock units (RSUs). On February 6, 2026, 381 shares of common stock were acquired upon RSU vesting, with 200 shares withheld at $127.42 per share for taxes, leaving 1,275 shares directly owned. On February 8, 2026, 398 shares were acquired from additional RSU vesting, with 209 shares withheld at $127.42, resulting in 1,464 common shares held directly after these transactions. Nicholas also holds 2,250.4257 RSUs, each representing a contingent right to receive one Zoetis common share as they vest over multi‑year schedules.
Zoetis Inc. Executive Vice President Roxanne Lagano reported routine equity compensation activity involving restricted stock units and common shares. On February 6, 2026, 544 shares of common stock were acquired upon RSU vesting, and 217 shares were withheld at a price of $127.42 for tax obligations. On February 8, 2026, a further 605 shares were acquired upon RSU vesting, with 221 shares withheld at $127.42 for taxes.
Following these transactions, Lagano directly owned 15,140 shares of Zoetis common stock and held 833.684 common stock equivalents indirectly through the Zoetis Savings Plan, a 401(k) plan, as of December 31, 2025. She also held 2,250.4257 RSUs that vest in installments on the first, second, and third anniversaries of the respective grant dates, subject to continued service and certain earlier-vesting events.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported equity award activity and tax-related share withholding. On February 6, 2026, 1,388 restricted stock units vested and were settled into common shares, with 515 shares withheld at $127.42 per share for taxes. On February 8, 2026, another 1,409 units vested into common shares, with 483 shares withheld at $127.42 per share for taxes. After these transactions, Wetteny directly owned 20,766 shares of Zoetis common stock and held 6,152.6517 RSUs that remain outstanding.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 6 and 8, 2026, RSUs vested and were settled into 206 and 218 shares of Zoetis common stock, respectively, with no cash exercise price.
To cover withholding obligations, the company withheld 92 and 97 shares of common stock at a price of $127.42 per share. After these transactions, the executive directly held 1,443 shares of Zoetis common stock and 1,294.6543 RSUs, which each represent a contingent right to receive one share of common stock as they vest over future anniversaries of the original grant dates.
Zoetis Inc. Executive Vice President Jamie Brannan reported routine equity compensation activity. On February 6 and 8, 2026, restricted stock units (RSUs) vested and were settled in Zoetis common stock, resulting in acquisitions of 529 and 380 shares, respectively.
To cover tax withholding on these vestings, 249 shares on February 6 and 179 shares on February 8 were withheld at a price of $127.42 per share. After these transactions, Brannan directly owned 2,652 shares of Zoetis common stock and held 445 common stock equivalents indirectly through the UK Share Ownership Plan.
The filing also shows 3,614.0741 RSUs outstanding under the Zoetis Amended and Restated 2013 Equity and Incentive Plan and related dividend equivalents, which represent contingent rights to receive the same number of Zoetis common shares upon future vesting.
Zoetis Inc. Executive Vice President Rimma Driscoll reported routine equity compensation activity involving restricted stock units (RSUs) and common stock. On February 6, 2026, 222 shares of common stock were acquired upon RSU vesting, and 89 shares were withheld at a price of $127.42 per share to cover taxes, leaving 5,325 shares of common stock directly owned. On February 8, 2026, a further 192 shares were acquired upon RSU vesting, with 77 shares withheld at $127.42 per share for taxes, resulting in 5,440 directly owned shares. The derivative table shows related RSU positions, including ongoing RSU awards that vest in thirds on the first, second, and third anniversaries of the original grant dates.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported routine equity compensation activity. On February 6, 2026, 119 shares of common stock were acquired upon vesting and settlement of restricted stock units, and 48 shares were withheld at $127.42 per share to cover taxes.
After these transactions, Sarbaugh directly owns 2,110 shares of Zoetis common stock. He also holds time-based restricted stock units that each represent a contingent right to receive one share, including 120 RSUs from a February 6, 2024 grant, 1,528.0167 RSUs from a March 31, 2023 grant, and 1,159.7099 RSUs from a February 19, 2025 grant, all vesting in three equal annual installments subject to continued service.
Zoetis Inc. Chief Executive Officer and director Kristin C. Peck reported multiple equity transactions involving company stock and restricted stock units (RSUs). On February 6, 2026, RSU vesting led to the acquisition of 5,555 shares of common stock, followed by the disposition of 1,914 shares at $127.42 per share. On February 8, 2026, additional RSUs vested, generating 6,224 shares of common stock, with 2,722 shares disposed of at $127.42 per share.
After these transactions, Peck directly held 101,337 shares of Zoetis common stock and 833.6435 common stock equivalents in the Zoetis Savings Plan (401(k)) as of December 31, 2025, along with 22,062.8977 RSUs outstanding under the company’s equity incentive plan.
Zoetis Inc. chief executive Kristin C. Peck reported an acquisition of 367.2079 phantom stock units on January 9, 2026, under the Zoetis Supplemental Savings Plan. These units are a form of deferred, cash-settled compensation whose value is tied to Zoetis common stock plus a small portion of cash-equivalent investments. After this transaction, Peck holds a total of 58,410.776 phantom stock units directly. Each unit represents a fraction of a phantom share of Zoetis common stock and typically includes around 5% of its value in cash-equivalent investments, so the total value moves with the Zoetis share price and the value of those cash-equivalent holdings.
Zoetis Inc. Executive Vice President Keith Sarbaugh reported an acquisition of derivative-based compensation tied to the company’s stock. On 01/09/2026, he acquired 149.604 phantom stock units under the Zoetis Supplemental Savings Plan at a reference value of $42.42 per unit, bringing his holdings in this plan-related instrument to 1,247.7606 phantom stock units held directly.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, which typically account for around 5% of the unit’s total value. The units are settled in cash following his separation from service, and their value is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments.
Zoetis Inc. Executive Vice President Kevin Esch reported an award of cash-settled phantom stock units linked to Zoetis common stock. On 01/09/2026, he acquired 100.6422 phantom stock units at a reference value of $42.42 per unit, bringing his total to 277.038 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and will be settled in cash after his separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small portion of cash-equivalent investments, with the value determined by the market price of Zoetis stock and the value of those cash-equivalent holdings.
Zoetis Inc. Chief Financial Officer Joseph Wetteny reported acquiring 217.6054 phantom stock units on January 9, 2026 at a reference price of $42.42 per unit. After this transaction, he holds a total of 6,803.5995 phantom stock units in a company plan. These units were acquired under the Zoetis Supplemental Savings Plan and are designed to be settled in cash after his separation from service, rather than in actual Zoetis shares.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, which typically makes up around 5% of the unit’s total value. The value of the units is determined by the market value of Zoetis common stock together with the value of the cash-equivalent investments, so their value moves generally in line with the stock over time.
Zoetis Inc. Executive Vice President Rimma Driscoll reported an acquisition of 141.4427 phantom stock units on January 9, 2026. These units were credited at a reference value of $42.42 per unit under the Zoetis Supplemental Savings Plan, bringing her total phantom stock unit balance to 5,367.8047 units held as a direct interest. The phantom stock units are settled in cash after her separation from service, and their value is determined by the market value of Zoetis common stock plus a small portion in cash-equivalent investments, which typically represent around 5% of each unit’s total value.
Zoetis Inc. Executive Vice President Roxanne Lagano reported acquiring 190.4046 phantom stock units on January 9, 2026, at a transaction price of $42.42 per unit. Following this transaction, she beneficially owns 28,815.1316 phantom stock units.
The units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s total value. The value of these units is determined by the market value of Zoetis common stock and the associated cash-equivalent investments.
Zoetis Inc. executive Julie Fuller reported a new grant of 190.4045 phantom stock units on January 9, 2026. The filing shows the units were acquired at a reference value of $42.42 per unit, bringing her total phantom stock unit balance to 578.0564 held directly.
These phantom stock units were acquired under the Zoetis Supplemental Savings Plan and are settled in cash after her separation from service. Each unit represents a fraction of a phantom share of Zoetis common stock plus a small cash-equivalent component, with the cash-equivalent investments typically around 5% of the unit’s total value. The value of the award therefore tracks the market value of Zoetis common stock together with the related cash-equivalent investments.
Zoetis Inc. disclosed a Form 4 reporting an equity award to one of its directors. On 12/01/2025, the director received 1,964 restricted stock units (RSUs) under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan at an exercise price of $127.25 per unit.
Each RSU represents a contingent right to receive one share of Zoetis common stock. The RSUs are scheduled to vest and be settled in Zoetis common shares on the first anniversary of the grant date, December 1, 2025, provided the director continues to serve through that date, with potential earlier vesting upon certain specified events.
Zoetis Inc. (ZTS) reported an insider transaction by an Executive Vice President. On 10/10/2025, the officer acquired 204.6185 phantom stock units at $46.71 per unit under the Zoetis Supplemental Savings Plan, bringing total derivative holdings to 10,990.0773 units (direct ownership).
The phantom units are cash-settled after separation from service. Each unit’s value tracks Zoetis common stock and includes a small cash-equivalent component typically around 5%.